Dare Bioscience, Inc.
DARE • NASDAQ
Dare Bioscience, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sabrina Martucci Johnson, with a market cap of $24.0M.
CEOSabrina Martucci Johnson
Market Cap$24.0M
Biotechnology
Healthcare
Employees26.0
Websitedarebioscience.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Dare Bioscience, Inc.
Date
Monday, March 30, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.38
Revenue Estimate
$1.0M
Earnings History
Past 12 earnings reports for Dare Bioscience, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Q3 2025 | -$0.28Est: -$0.36 | +22.2% | $2.3KEst: $21.9K | -89.6% |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.45Est: -$0.57 | +21.1% | -Est: $312.9K | -100.0% | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.50Est: -$0.63 | +20.6% | $25.4KEst: $600.0K | -95.8% | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.65Est: -$0.63 | -3.2% | -$63.6KEst: $1.0M | -106.4% | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.55Est: -$0.71 | +22.5% | $41.7KEst: $2.0M | -97.9% | 10-Q |
| Aug 12, 2024 | Q2 2024 | $1.52 | — | $22.4MEst: $5.9M | +281.0% | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.84Est: -$0.72 | -16.7% | $9.3MEst: $260.0K | +3477.7% | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$0.72Est: -$1.20 | +40.0% | $1.8MEst: $1.8M | +1.0% | 10-K |
| Nov 9, 2023 | Q3 2023 | -$1.08Est: -$1.20 | +10.0% | $1.0MEst: $430.0K | +132.6% | — |
| Aug 10, 2023 | Q2 2023 | -$1.20Est: -$0.10 | -1100.0% | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$1.08Est: -$1.20 | +10.0% | -Est: $1.7M | -100.0% | 10-Q |
| Mar 30, 2023 | Q4 2022 | -$2.28Est: -$1.68 | -35.7% | - | — | — |